Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EW vs MRNA✓SelectedUSD · MRNAEW vs MRNA performance historyLatest closeAs of-0.04%11/16
Stock and ETF performance explorer

EW vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-10.0%
MRNA return
-8.0%
Excess return
-2.0%
Maximum drawdown
-54.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.6%+3.6%+0.1%
7D+2.3%-20.0%+22.3%+3.2%
30D+23.7%-1.3%+24.9%+23.6%
3M+16.9%+240.0%-223.0%+7.6%
6M+31.6%+339.0%-307.4%+17.8%
YTD+25.6%+630.0%-604.3%+6.6%
1Y+24.1%+769.1%-745.0%+3.4%
3Y+58.8%+181.2%-122.5%+40.9%
5Y-10.0%-8.1%-1.9%-17.1%
All-10.0%-8.0%-2.0%-17.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling